Cardinal Health, Inc. Derivative Asset Designated as Hedging Instrument, Fair Value (Deprecated 2011-01-31)
Cardinal Health, Inc. (CAH) had Derivative Asset Designated as Hedging Instrument, Fair Value (Deprecated 2011-01-31) of $27.30 million as of 2010-06-30, per its 10-K/A filed 2010-09-02.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:DerivativeAssetDesignatedAsHedgingInstrumentFairValue · last filed 2010-09-02
- 2010-06-30: Derivative Asset Designated as Hedging Instrument, Fair Value (Deprecated 2011-01-31) $27.30M.
- 2009-06-30: Derivative Asset Designated as Hedging Instrument, Fair Value (Deprecated 2011-01-31) $1.60M.
| Period end | Derivative Asset Designated as Hedging Instrument, Fair Value (Deprecated 2011-01-31) |
|---|---|
| 2010-06-30 | $27.30M 10-K/A · filed 2010-09-02 |
| 2009-06-30 | $1.60M 10-K/A · filed 2010-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |